New immunostimulatory synthetic compounds for the Treatment of Leishmaniasis and Tuberculosis
The current treatments for tuberculosis and leishmaniosis have many drawbacks: long treatment duration,appearance of resistances,toxic side effects. Our new treatment suggests an immune activator based on a synthetic analogue of an active glycolipid.
Further information: PDF
TuTech Innovation GmbH (TuTech)
Phone: +49 40 76629-6541
Contact
Dr. Markus Kähler
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles
“Segment-jumping” ridgecrest earthquakes explored
Seismologists use supercomputer to reveal complex dynamics of multi-fault earthquake systems. On the morning of July 4, 2019, a magnitude 6.4 earthquake struck the Searles Valley in California’s Mojave Desert,…
“Sustainable” condenser tumble dryers
… create hundreds of tonnes of waterborne microfiber pollution. A new study has revealed that drying laundry using a condenser tumble dryer leads to hundreds of tonnes of potentially harmful…
Not so biodegradable
New study finds bio-based plastic and plastic-blend textiles do not biodegrade in the ocean. First-of-its-kind experiment off Scripps Pier finds only natural fibers degrade in the marine environment; plastic fabrics…

















